| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P2093 | author name string | Vlad Ratziu | |
| Hashem B El-Serag | |||
| Donna L White | |||
| P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
| Involvement of the PA28 -Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein | Q27478049 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Prevalence of Type-2 diabetes in patients with hepatitis C and B virus infection in Jeddah, Saudi Arabia | Q33343259 | ||
| Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach | Q33998250 | ||
| A simulation study of the number of events per variable in logistic regression analysis | Q34411363 | ||
| Association of diabetes mellitus and chronic hepatitis C virus infection. | Q34756492 | ||
| Association between hepatitis C virus infection and diabetes mellitus | Q34794299 | ||
| Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt | Q35956085 | ||
| Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies | Q36257275 | ||
| Epidemiology of viral hepatitis and HIV co-infection | Q36341016 | ||
| Hepatitis C infection and diabetes | Q36408033 | ||
| Association of chronic hepatitis C infection and diabetes mellitus | Q38990484 | ||
| Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis | Q40345798 | ||
| Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance | Q42457824 | ||
| Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis | Q42498476 | ||
| Hepatitis C virus infection and human pancreatic beta-cell dysfunction | Q42991508 | ||
| Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study | Q42992992 | ||
| Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection | Q42995347 | ||
| Correlation between insulin resistance and hepatitis C viral load | Q42999627 | ||
| Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. | Q42999758 | ||
| Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. | Q43032825 | ||
| Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. | Q43034614 | ||
| Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders | Q43037031 | ||
| Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans | Q43048280 | ||
| Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users | Q43048603 | ||
| Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus | Q43048623 | ||
| Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients | Q43623180 | ||
| Diabetes mellitus is equally frequent in chronic HCV and HBV infection | Q44248777 | ||
| Hepatitis C virus infection and incident type 2 diabetes | Q44493737 | ||
| Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients | Q44586614 | ||
| Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. | Q44643929 | ||
| High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury | Q44865669 | ||
| Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection | Q44967738 | ||
| Extrahepatic manifestations of hepatitis C among United States male veterans | Q45333951 | ||
| Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients | Q45396986 | ||
| Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study | Q45404126 | ||
| Hepatitis C virus infection: evidence for an association with type 2 diabetes | Q45423687 | ||
| Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. | Q45699015 | ||
| Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States | Q45737067 | ||
| A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan | Q45745496 | ||
| High prevalence of hepatitis C virus infection in diabetic patients | Q45767196 | ||
| Hepatitis C as a risk factor for diabetes type 2: lack of evidence in a hospital in central-west Brazil | Q46540965 | ||
| Antiretroviral drugs and liver injury | Q46843085 | ||
| Effect of antiretroviral therapy and hepatitis c co-infection on changes in lipid levels in HIV-Infected patients 48 weeks after initiation of therapy | Q46879484 | ||
| A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort. | Q51480142 | ||
| Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study | Q56529459 | ||
| Hepatitis C Viremia Increases the Association With Type 2 Diabetes Mellitus in a Hepatitis B and C Endemic Area: An Epidemiological Link With Virological Implication | Q57982384 | ||
| Is diabetes mellitus a risk factor for HCV infection? | Q73130350 | ||
| Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation | Q73929838 | ||
| Increased frequency of HCV but not HBV infection in type 2 diabetic patients in Turkey | Q74129358 | ||
| NIH Consensus Statement on Management of Hepatitis C: 2002 | Q75442808 | ||
| Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factors | Q81458510 | ||
| Seroprevalence of hepatitis B and C in type 2 diabetic patients | Q83320136 | ||
| Increased frequency of HCV and HBV infection in type 2 diabetic patients | Q93934003 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| meta-analysis | Q815382 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 831-844 | |
| P577 | publication date | 2008-08-21 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis | |
| P478 | volume | 49 |
| Q92432698 | A SEVERE CASE OF HYPERGLYCEMIA IN A KIDNEY TRANSPLANT RECIPIENT UNDERGOING INTERFERON-FREE THERAPY FOR CHRONIC HEPATITIS C |
| Q57173478 | A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study |
| Q33556547 | A meta-analysis of the association between gestational diabetes mellitus and chronic hepatitis B infection during pregnancy |
| Q47140391 | A preliminary analysis of hepatitis C virus in pancreatic islet cells. |
| Q39478220 | Association of Overt Diabetes Mellitus with the Non-CC but not the CC Genotype of Interleukin-28B in Hepatitis C Virus Infected Patients |
| Q47911394 | Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity |
| Q36840571 | Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS). |
| Q42271138 | Association of suppressor of cytokine signalling 3 polymorphisms with insulin resistance in patients with chronic hepatitis C. |
| Q50047481 | Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study |
| Q60303063 | Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017) |
| Q43625948 | Cardiovascular risk factors after liver transplantation: analysis of related factors |
| Q58785077 | Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy |
| Q36180921 | Chronic Liver Disease-Associated Hospitalizations Among Adults with Diabetes, National Inpatient Sample, 2001-2012. |
| Q42287458 | Chronic hepatitis C infection is associated with insulin resistance and lipid profiles |
| Q28082212 | Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview |
| Q33402027 | Community-based cross-sectional study: the association of lipids with hepatitis C seropositivity and diabetes mellitus |
| Q37610878 | Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review |
| Q37903853 | Current understanding of insulin resistance in hepatitis C. |
| Q40469321 | Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis. |
| Q42102990 | Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients |
| Q88581891 | Diabetes With or Without Hypertension Does Not Affect Graft Survival and All-cause Mortality After Liver Transplant: A Propensity Score Matching Analysis |
| Q57180651 | Diabetes and HIV |
| Q36056076 | Diabetes and Hepatitis C: A Two-Way Association |
| Q38086739 | Diabetes and infections-hepatitis C: is there type 2 diabetes excess in hepatitis C infection? |
| Q37962197 | Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences |
| Q39664082 | Diabetes mellitus impairs the response to intra-arterial chemotherapy in hepatocellular carcinoma |
| Q37685491 | Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review |
| Q40418302 | Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort study |
| Q51249807 | Diagnosis and Clinical Implications of Diabetes in Liver Cirrhosis: A Focus on the Oral Glucose Tolerance Test. |
| Q34171033 | Does hepatitis C virus infection increase risk for stroke? A population-based cohort study |
| Q37279353 | Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies |
| Q90643079 | Effect of HCV treatment response on insulin resistance: A systematic review and meta-analysis |
| Q39556422 | Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: comparison between different genotypes and core protein sequence analysis |
| Q37046576 | Effects of metabolic syndrome on fibrosis in chronic viral hepatitis |
| Q59349480 | Endocrine disorders associated with hepatitis C virus chronic infection |
| Q34057855 | Endoplasmic reticulum stress links hepatitis C virus RNA replication to wild-type PGC-1α/liver-specific PGC-1α upregulation |
| Q38684508 | Extrahepatic manifestations of HCV: the role of direct acting antivirals |
| Q28079826 | Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV |
| Q41495145 | Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection |
| Q92385797 | Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study |
| Q42259738 | Global confluence of infectious and non-communicable diseases -- the case of type 2 diabetes |
| Q30240220 | Global epidemiology and burden of HCV infection and HCV-related disease |
| Q36277992 | Glucose abnormalities in Asian patients with chronic hepatitis C |
| Q91785618 | HCV Extrahepatic Manifestations |
| Q40084859 | HCV-infected Renal Transplant Recipients: Our Experience before the Availability of New Antiviral Drugs |
| Q41533775 | Hepatitis B virus infection status and risk of type 2 diabetes mellitus: A meta-analysis |
| Q64086117 | Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose Parameters |
| Q59351137 | Hepatitis C Virus Infection at Primary Healthcare Level in Abha City, Southwestern Saudi Arabia: Is Type 2 Diabetes Mellitus an Associated Factor? |
| Q26751755 | Hepatitis C Virus, Insulin Resistance, and Steatosis |
| Q37432092 | Hepatitis C and diabetes: the inevitable coincidence? |
| Q26775000 | Hepatitis C and insulin action: An intimate relationship |
| Q26775815 | Hepatitis C genotype 4: The past, present, and future |
| Q33713718 | Hepatitis C infection in Egypt: prevalence, impact and management strategies |
| Q37386098 | Hepatitis C virus and glucose and lipid metabolism |
| Q24658049 | Hepatitis C virus and type 2 diabetes |
| Q26776387 | Hepatitis C virus as a systemic disease: reaching beyond the liver |
| Q37390189 | Hepatitis C virus in pregnancy |
| Q37980432 | Hepatitis C virus induced insulin resistance impairs response to anti viral therapy |
| Q38701810 | Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice. |
| Q47555610 | Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature |
| Q45354125 | Hepatitis C virus infection and diabetes: not a straightforward relationship |
| Q38236820 | Hepatitis C virus infection and kidney transplantation in 2014: what's new? |
| Q26863156 | Hepatitis C virus infection and risk of stroke: a systematic review and meta-analysis |
| Q26829202 | Hepatitis C virus infection and type 1 and type 2 diabetes mellitus |
| Q64295689 | Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure |
| Q59789662 | Hepatitis C virus infections and associated risk factors in patients with diabetes mellitus; case control study in North West Tigray, Ethiopia |
| Q39241528 | Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy |
| Q37527686 | Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies |
| Q52661702 | Hepatitis C virus: Morphogenesis, infection and therapy. |
| Q27026753 | Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific region |
| Q37389382 | Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes |
| Q42245782 | Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial |
| Q40724787 | Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study |
| Q46597840 | Impact of moderate alcohol discontinuation on insulin action and secretion in Latinos with and without hepatitis C. |
| Q44011725 | Impact of preexisting diabetes mellitus on outcome after liver transplantation in patients with hepatitis B virus-related liver disease |
| Q64136945 | Incidence of primary liver cancer in American Indians and Alaska Natives, US, 1999-2009 |
| Q41039250 | Increase in nonhepatic diagnoses among persons with hepatitis C hospitalized for any cause, United States, 2004-2011. |
| Q59357759 | Increased body fat percentage in patients with hepatitis B and C virus infection |
| Q61910384 | Infections virales et diabète en Afrique |
| Q88881039 | Insulin resistance and its consequences in chronic hepatitis C |
| Q42024080 | Insulin resistance in non-diabetic patients of chronic Hepatitis C. |
| Q39240971 | Insulin resistance, steatosis and hepatitis C virus. |
| Q37328650 | Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan |
| Q37627175 | Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009-2010. |
| Q34128534 | Is hepatitis C associated with atherosclerotic burden? A systematic review and meta-analysis |
| Q34034846 | Lack of association between hepatitis C infection and chronic kidney disease |
| Q27010631 | Liver steatosis in hepatitis C patients |
| Q39972632 | Matched population-based study examining the risk of type 2 diabetes in people with and without diagnosed hepatitis C virus infection |
| Q43037279 | Meta-analysis: insulin resistance and sustained virological response in hepatitis C. |
| Q37151984 | Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection |
| Q30369757 | Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy? |
| Q42237381 | Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010. |
| Q50934392 | Natural History of Hepatitis C. |
| Q55553786 | Orbital Pseudotumor as an Extrahepatic Complication of Chronic HCV Infection. |
| Q26861095 | Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen |
| Q27022707 | Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis |
| Q28481414 | Pioglitazone decreases hepatitis C viral load in overweight, treatment naïve, genotype 4 infected-patients: a pilot study |
| Q35868937 | Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. |
| Q50145783 | Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment |
| Q44340041 | Predictors of diabetes mellitus and abnormal blood glucose in patients receiving opioid maintenance treatment |
| Q33572101 | Prevalence of Diabetes Type 2 in Hepatitis C Infected Patients in Kpk, Pakistan |
| Q59801984 | Prevalence of serological markers for hepatitis and potential associated factors in patients with diabetes mellitus |
| Q64107246 | Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis |
| Q37105110 | Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian study |
| Q38081919 | Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor. |
| Q33798375 | Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial |
| Q48091665 | Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: A driver function of circulating miRNAs |
| Q35886690 | Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. |
| Q34005936 | Relationship of hepatitis C virus infection with diabetes in the U.S. population |
| Q27026577 | Renal dysfunction in liver transplant recipients: evaluation of the critical issues |
| Q86022770 | Reply |
| Q38198089 | Review article: genetic factors that modify the outcome of viral hepatitis |
| Q34062040 | Review. |
| Q41919194 | Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status |
| Q47169604 | Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review. |
| Q58759355 | Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy: A nationwide population-based study |
| Q41928201 | SIGNIFICANT IMPROVEMENT OF GLYCAEMIC CONTROL IN DIABETIC PATIENTS WITH HCV INFECTION RESPONDING TO DIRECT-ACTING ANTIVIRAL AGENTS. |
| Q64064930 | Seroprevalence and trend of human immunodeficiency virus among blood donors in Ethiopia: a systematic review and meta-analysis |
| Q34351092 | Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association |
| Q30401616 | Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: a cross-sectional observational study |
| Q37607397 | Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C. |
| Q37622162 | Steatosis and insulin resistance in hepatitis C: a way out for the virus? |
| Q37974700 | Steatosis and insulin resistance in response to treatment of chronic hepatitis C. |
| Q40945393 | Successful Hepatitis C Antiviral Therapy Induces Remission of Type 2 Diabetes: A Case Report. |
| Q28068362 | Supplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini Review |
| Q34172595 | Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more |
| Q64134127 | Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C |
| Q42980606 | Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C. |
| Q64132378 | Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes |
| Q89860205 | The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm |
| Q35824137 | The Impact of Hepatitis B Vaccination Status on the Risk of Diabetes, Implicating Diabetes Risk Reduction by Successful Vaccination |
| Q64254430 | The Role of ApoE in HCV Infection and Comorbidity |
| Q30870794 | The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients |
| Q38716514 | The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection. |
| Q57127580 | The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment |
| Q37711317 | The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients |
| Q39097973 | The subgingival microbiome, systemic inflammation and insulin resistance: The Oral Infections, Glucose Intolerance and Insulin Resistance Study. |
| Q50550145 | Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers. |
| Q26776338 | Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality? |
| Q39177080 | Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis. |
| Q26752583 | Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight |
| Q38351750 | Type 2 diabetes mellitus and the risk of hepatitis C virus infection: a systematic review |
| Q43516161 | Type 2 diabetes mellitus in chronic hepatitis C virus infection: risk factor or consequence? |
| Q37931383 | Use of HOMA-IR in hepatitis C. |
| Q28072257 | Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence |
| Q38952609 | Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination |
| Q42990978 | Virus C hepatitis and type 2 diabetes: a cohort study in southern Italy |
Search more.